Repligen
RGEN
#2692
Rank
C$8.96 B
Marketcap
C$159.01
Share price
1.49%
Change (1 day)
-2.03%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): C$0.11 Billion

According to Repligen 's latest financial reports the company's current earnings are C$0.73 Billion. , an increase over its 2024 earnings that were of -C$8.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 C$0.11 B-1430.84%
2024 -C$8.72 Million-113.01%
2023 C$66.95 M-78.01%
2022 C$0.30 B33.37%
2021 C$0.22 B131.52%
2020 C$98.6 M101.31%
2019 C$48.98 M25.93%
2018 C$38.89 M105.61%
2017 C$18.91 M-11.46%
2016 C$21.36 M14.91%
2015 C$18.59 M20.26%
2014 C$15.46 M-51.49%
2013 C$31.87 M90.98%
2012 C$16.68 M
2010 C$0.24 M-103.81%
2009 -C$6.34 Million-223.84%
2008 C$5.11 M
2006 -C$3.44 Million229.64%
2005 -C$1.05 Million-89.16%
2004 -C$9.63 Million-16.86%
2003 -C$11.58 Million88.72%
2002 -C$6.14 Million-27.88%
2001 -C$8.51 Million-1.74%
2000 -C$8.66 Million85.93%
1999 -C$4.66 Million159.16%
1998 -C$1.8 Million85.71%
1997 -C$0.97 Million-70.83%
1996 -C$3.32 Million-72.41%
1995 -C$12.03 Million-60.63%
1994 -C$30.55 Million45.39%
1993 -C$21.01 Million39.45%
1992 -C$15.07 Million-32.3%
1991 -C$22.26 Million6.62%
1990 -C$20.87 Million1577.78%
1989 -C$1.25 Million-57.14%
1988 -C$2.91 Million-362.5%
1987 C$1.1 M-130.77%
1986 -C$3.6 Million136.36%
1985 -C$1.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.63 B 12,523.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$10.25 B 8,746.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$15.17 B 12,988.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.26 B 11,339.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-C$0.16 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$0.64 B 453.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$1.10 B 852.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.17 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.53 B 359.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-C$0.14 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA